The quality of life of patients with end-stage renal disease, N Engl J Med, vol.312, pp.553-562, 1985. ,
Annual Data Report: kidney, Am J Transplant, vol.15, issue.2, pp.1-34, 2013. ,
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, vol.341, pp.1725-1755, 1999. ,
Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success, Am J Transplant, vol.11, pp.1226-1261, 2011. ,
What are the key challenges we face in kidney transplantation today?, Transplant Res, vol.2, p.1, 2013. ,
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure, Am J Transplant, vol.9, pp.2520-2551, 2009. ,
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, vol.12, pp.388-99, 2012. ,
Reference Guide to the Banff Classification of Renal Allograft Pathology Transplantation, vol.11, pp.1795-1814, 2018. ,
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, pp.272-83, 2014. ,
The clinical impact of chronic transplant glomerulopathy in cyclosporine era, Transplantation, vol.80, pp.1392-1399, 2005. ,
Transplant glomerulopathy: subclinical incidence and association with alloantibody, Am J Transplant, vol.7, pp.2124-2156, 2007. ,
Antibody-mediated rejection criteriaan addition to the Banff 97 classification of renal allograft rejection, Am J Transplant, vol.3, pp.708-722, 2003. ,
Antibody-mediated rejection in renal allografts: lessons from pathology, Clin J Am Soc Nephrol, vol.1, pp.415-435, 2006. ,
Endothelial gene expression in kidney transplants with alloantibody indicates antibodymediated damage despite lack of C4d staining, Am J Transplant, vol.9, pp.2312-2335, 2009. ,
The Banff 97 working classification of renal allograft pathology, Kidney Int, vol.55, pp.713-736, 1999. ,
05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'), Am J Transplant, vol.7, pp.518-544, 2007. ,
Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, vol.8, pp.753-60, 2008. ,
09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, vol.10, pp.464-71, 2010. ,
Meeting report: new concepts in antibody-mediated rejection, Am J Transplant, vol.12, pp.563-70, 2011. ,
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, pp.272-83, 2014. ,
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection, Transplantation, vol.49, pp.85-91, 1990. ,
Capillary deposition of C4d complement fragment and early renal graft loss, Kidney Int, vol.43, pp.1333-1341, 1993. ,
,
, Nephrol Ther, vol.4, issue.3, pp.188-91, 2008.
Antibody-mediated vascular rejection of kidney allografts: a population-based study, Lancet, vol.381, pp.313-322, 2013. ,
Antibody-mediated rejection in renal allografts: lessons from pathology, Clin J Am Soc Nephrol, vol.1, pp.415-435, 2006. ,
The utility of 1-and 3-month protocol biopsies on renal allograft function: a randomized controlled study, Am J Transplant, vol.8, issue.2, pp.317-340, 2008. ,
Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection : a pilot study, J Am Soc Nephrol, vol.10, pp.1801-1806, 1999. ,
Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation, vol.100, pp.1610-1618, 2016. ,
Propensity Score: an Alternative Method of Analyzing Treatment Effects, World Kidney Day: Chronic Kidney Disease, vol.113, pp.597-603, 2015. ,
The quality of life of patients with end-stage renal disease, N Engl J Med, vol.312, pp.553-562, 1985. ,
Annual Data Report: kidney, Am J Transplant, vol.15, issue.2, pp.1-34, 2013. ,
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, vol.341, pp.1725-1755, 1999. ,
Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success, Am J Transplant, vol.11, pp.1226-1261, 2011. ,
What are the key challenges we face in kidney transplantation today?, Transplant Res, vol.2, p.1, 2013. ,
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, vol.12, pp.388-99, 2012. ,
, Transplantation Journal, vol.65, issue.11, pp.1506-1509, 1998.
, , p.249, 2004.
,
, Transplantation, vol.71, issue.4, pp.515-523, 1995.
Ranganna et al different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-Transplant Immunology, vol.20, pp.32-42, 2008. ,
Shin et al protocol biopsy in living-donor renal transplantation: ten-year experience at a 1360, 2005. ,
, , vol.6, 2006.
,
, American Journal of Transplantation, vol.7, issue.3, pp.512-517, 2007.
Bachmann et al 908 913, Chronic Kidney Disease, vol.17, pp.326-331, 2006. ,
, 20. protocol biopsy at one month posttransplantation in deceased-donor renal 214, 2007. 21. -term protocol biopsies after kidney 5, Kidne American Journal of Transplantation, vol.11, issue.8, pp.1570-1575, 2011.
Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, vol.8, pp.753-60, 2008. ,
Protocol biopsies in renal transplantation: research tool or clinically useful?, Cur Opin Nephrol Hypertens, vol.7, pp.691-694, 1998. ,
The utility of 1-and 3-month protocol biopsies on renal allograft function: a randomized controlled study, Am J Transplant, vol.8, issue.2, pp.317-340, 2008. ,
, plant protocol of Transplantation, vol.5, issue.8, 2005.
Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies, Transplantation, vol.50, issue.5, pp.790-797, 1990. ,
, , vol.973, 2003.
Complications of Ultrasound-Guided Renal Transplant Biopsies, Am J Transplant, vol.16, issue.4, pp.1298-305, 2016. ,
Subclinical rejection intacrolimus-treated renal transplant recipients, Transplantation, vol.73, issue.12, pp.1965-1968, 2002. ,
Baseline immunosuppression is associated with histological findings in early protocol biopsiesTransplantation, vol.78, pp.1064-10687, 2004. ,
Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation, vol.100, pp.1610-1618, 2016. ,
Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings ,
Successful steroid withdrawal guided by surveillance biopsies-A single-center experience, Clin Transplant, vol.32, issue.3, p.13181, 2018. ,
Alexander Kainz Steroids and ciclosporin withdrawal after renal transplantation: a retrospective cohort study, BMC Med, vol.15, p.8, 2017. ,
Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies, Am J Transplant, vol.16, issue.1, pp.194-203, 2016. ,
Y-a-t-il un intérêt à réaliser une ponction biopsie rénale protocolaire à 3 mois après transplantation rénale, 2018. ,
Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients, Transplant Proc, vol.49, issue.8, pp.1724-1728, 2017. ,
Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients, Clin Transplant, issue.5, p.31, 2017. ,
Propensity Score: an Alternative Method of Analyzing Treatment Effects, Dtsch Arztebl Int, vol.113, pp.597-603, 2016. ,
, Supplementary Material SM 1: Graft survival with respect to ci and ct lesions SM 2: Graft survival with respect to cv lesions SM 3: graft survival for the 2009 cohort